Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma

ConclusionsIn a large modern cohort identified from the NCDB, commercial insurance status in patients<65  years was associated early diagnosis, receipt of neoadjuvant/adjuvant radiation therapy, and overall survival for patients with soft tissue sarcoma. Further efforts are warranted to understand disparities in care based on health insurance in the United States.

Source: Cancer Medicine - September 3, 2019 Category: Cancer & Oncology Authors: Varsha Jain, Sriram Venigalla, Ronnie A. Sebro, Giorgos C. Karakousis, Robert J. Wilson, Kristy L. Weber, Jacob E. Shabason Tags: ORIGINAL RESEARCH Source Type: research